Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Arrail Group›
Analysis
AddedJul 2, 2026
UpdatedJul 2, 2026
Arrail Group

Arrail Group

Arrail Group provides premium private dental services in China via Arrail Dental and Rytime Dental brands.

HQ
Beijing, Beijing, CN
Founded
1999
Loading
Overview
Analysis
Compare
Employees
News
Website
Number of Customers
11,000,000
Revenue Estimate
$1.7B

Contents

  1. 01Products & Services
  2. 02Market Outlook
  3. 03Competitive Strengths
  1. 01Products & Services
  2. 02Market Outlook
  3. 03Competitive Strengths

Product Overview

Arrail Group operates a nationwide network of dental clinics and hospitals in China under a dual-brand strategy. Its Arrail Dental brand targets the premium private dental services segment, while its Rytime Dental brand serves the mid-end market, together covering patients of different economic and geographic backgrounds.

As of September 30, 2024, the group ran 123 stores, including 112 dental clinics and 11 hospitals across 15 Chinese cities, providing a wide array of general and specialty dental healthcare services. The company has served approximately 11.0 million patient visits over the past ten years and books treatment through its clinic network and dedicated contact lines.

Market Outlook

China's private dental services market has grown as public awareness of oral health and dental care has risen, with premium private providers capturing increasing share from public hospital dental departments. Frost & Sullivan data cited in Arrail Group's listing materials positioned the company as the largest player in the premium private dental service market by 2020 revenue and the third largest across China's entire private dental service market.

The market remains structurally regional, with top-tier medical resources concentrated in first-tier cities, which favors scaled national chains able to move expertise across regions. The implementation of centralized procurement policy has pushed the sector toward rational, quality-driven competition, while digital dentistry and AI-assisted workflows are emerging as the next axis of differentiation among larger clinic groups.

Competitive Advantages

According to Frost & Sullivan, Arrail Group was the largest dental services provider in China's premium private dental service market based on 2020 revenue, and the only listed national dental chain institution in the market. Its nationwide footprint covers 15 first- and second-tier cities across four core regions, a scale few competitors can match given the regional character of dental services.

The group backs its premium positioning with a deep medical team and standardized operations. As of September 2021 it employed 882 senior dentists, more than half holding a master's degree or higher with an average 10.2 years of experience, and it rolled out a standardized digital platform and SaaS system for dental operations, procurement, medical records, and patient relationship management across its hospitals and clinics.